On the 18th of December, the ACGS celebrated the annual 2020 NHS bioinformatician meeting remotely in Cardiff. Below are some highlighted notes from this significant event.
**Opening and Introduction**:
The conference kicked off with a formal introduction about the committees and the collaborating organizations involved in this event, including BMGS, CGS, FGG, CGG, and AGNC. An announcement was also made about the next ACGS conference, planned for 2021 in Birmingham. Communication regarding the organization of this upcoming event and other matters will be disseminated via Slack and Github.
**First Presentation: Genomic Partnership of Wales (GPW)**:
Tom Connor from Public Health Wales started the meeting by detailing the services supported by GPW and its collaborations with other NHS departments (such as epidemiology, microbiology, and IT infrastructure) as well as entities outside the NHS like academic bodies and private sector companies. He continued to discuss GPW's work related to COVID-19. Since sequencing the first Welsh SARS-Cov-2 genome in March 2020, GPW sequenced over 15,000 genomes by December. This effort allowed for genomic analyses to trace the virus's ancestry, identify transmission across the country, and study variants from different nations. For instance, Spain was identified as the predominant source of cases from February to March.
This presentation was particularly enlightening for me, offering insights into the direct applications of bioinformatics in current clinical and societal challenges. Tom emphasized how the government used this genomic data to make informed decisions about travel restrictions based on the origin of new cases.
**Second Presentation: Wales Infants and Children’s Genome Service (WINGS)**:
Joseph Halstead from All Wales Medical Genomics Service provided a technical overview of WINGS, a new service for rapid diagnostic testing in critically ill children with unexplained rare disorders. Though quite technical and sometimes beyond my comprehension, this speech shed light on areas where I should deepen my focus.
**Update from The University of Manchester**:
Andrew Devereau updated us on the challenges faced by The University of Manchester, revealing that the second semester would be conducted entirely online. Despite this, most feedback has been positive.
**Short Presentations by STP Trainees**:
The second half of the conference featured four brief presentations by STP trainees. For example, Maria Lock introduced MosaicMiner, a new bioinformatics pipeline for low-frequency variants detection, while Laura McCluskey discussed an innovative NGS pipeline to detect fusion in RNA. These presentations were quite inspiring for my STP development and provided ideas for potential research projects.
**Conference Closing Discussion**:
The conference concluded with a brief discussion on various topics, though limited participation constrained the content. The subjects covered included:
1. **Adapting to Training during COVID-19**:
Adriana reported on a remote training event for STP Trainees in Cambridge using Zoom and Slack, highlighting positive feedback. Also mentioned were theme-based meetings for trainees and training officers, providing opportunities to discuss managing training during the pandemic.
2. **Somatic Bioinformatics Best Practice Guidelines**:
Progress on this work has stalled, and the speaker expressed a desire to expand the team working on this topic.
The meeting served as a valuable platform for sharing information, updates, and ideas among professionals in the field of bioinformatics. While some presentations were highly technical, the overall experience provided key insights and inspiration, underscoring the importance and adaptability of the field during these unprecedented times.
This blog contains short learning projects I will carry out during my Scientist Training Programme. Each publication will start with an introduction highlighting background and motivation follow by results and discussion to finish with some reflection when possible.
Sunday, 20 December 2020
Notes taken in the 2020 ACGS NHS Bioinformatics meeting
Monday, 14 December 2020
Good Scientific Practice
"An expert is a person who has made all the mistakes that can be made in a very narrow field"
-- Niels Bohn
Today, I want to explore a topic a bit different from the ones I usually address in this blog, but one that's incredibly vital to my profession: Good Scientific Practice (GSP). Specifically, I aim to offer a reflective thought on personal values, principles, and assumptions, and how these can influence personal judgment and professional behavior—all in relation to GSP. In this post, I will summarize what I believe are the significant principles and values underpinning the good practices conducted by a clinical bioinformatician.
I define GSP as a set of values and standards applied throughout the career of any professional involved in healthcare science. Healthcare professionals come from diverse fields, so these values must be contextualized for each particular role. However, a core ethos can be applied universally at any level of practice. In this brief document, I'll mention and explain this set of shared values before focusing on those especially pertinent to a clinical bioinformatician.
Clinical scientists often deal with patient care, and patient well-being is our foremost concern. Even though, as a bioinformatician, I don't interact with patients directly, I always keep in mind that each patient is an individual whose dignity and confidential data must be treated appropriately. To achieve this, several key elements need to be performed:
- Maintain up-to-date professional, technical, and scientific knowledge and skills to make sound judgments.
- Recognize your personal competence limits and consult or seek advice if unsure.
- Develop skills to work effectively as part of a multi-disciplinary team.
- Foster a friendly environment where colleagues are comfortable.
- Be proactive and seek to bring out the best in your team.
- Contribute to the education of colleagues, recognizing that each member has a unique background.
**Personal Experience**: Working in Cambridge, I recall a technician who was neither a leader nor a manager but was considered a key person in the group. For reasons unknown, this individual's absence for a few weeks caused the group to lose cohesion.
Since clinical scientists also engage in scientific pursuits, good practice includes not only research reliability but also technical excellence, quality, innovation, and development. Inherent principles of scientific method—such as objectivity, impartiality, fairness, credit attribution, and the responsibility to impart knowledge and train future scientists—must be maintained.
Science, especially genomics, is in constant flux, advancing rapidly. To be effective professionals, we must stay abreast of the latest developments in our field. Since much of our work involves diagnosis, treatment, screening, prognosis, and monitoring, it's vital to know the latest strategies and procedures to ensure quality and safety.
Good scientific practice also requires solid technical practices. This domain can be challenging to define, particularly in the context of a clinical genomics laboratory. Good technical practices involve principles designed to assure the quality and reliability of services. This includes adhering to methodologies, handling measurements and analysis, and managing risks associated with hazardous substances.
In clinical laboratories, ensuring a high level of quality and standardization is crucial. We must assess and evaluate new technologies in collaboration with peer laboratories, participate in quality assurance programs, develop standard operating procedures, and continuously seek improvement through effective audit trails.
In conclusion, this post represents a synthesis of ideas I've gleaned from my experiences, supplemented by additional research. Other important factors may exist that I've either forgotten or am not yet confident enough to discuss, such as those related to leadership and management. Nonetheless, the principles and practices I've outlined here provide a foundational understanding of the essential aspects of GSP in the field of clinical bioinformatics.